Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 150 (1), 15-20

Logic and Justification for Dimensional Assessment of Symptoms and Related Clinical Phenomena in Psychosis: Relevance to DSM-5


Logic and Justification for Dimensional Assessment of Symptoms and Related Clinical Phenomena in Psychosis: Relevance to DSM-5

Deanna M Barch et al. Schizophr Res.


Work on the causes and treatment of schizophrenia and other psychotic disorders has long recognized the heterogeneity of the symptoms that can be displayed by individuals with these illnesses. Further, researchers have increasingly emphasized the ways in which the severity of different symptoms of this illness can vary across individuals, and have provided evidence that the severity of such symptoms can predict other important aspects of the illness, such as the degree of cognitive and/or neurobiological deficits. Additionally, research has increasingly emphasized that the boundaries between nosological entities may not be categorical and that the comorbidity of disorders may reflect impairments in common dimensions of genetic variation, human behavior and neurobiological function. As such, it is critical to focus on a dimensional approach to the assessment of symptoms and clinically relevant phenomena in psychosis, so as to increase attention to and understanding of the causes and consequences of such variation. In the current article, we review the logic and justification for including dimensional assessment of clinical symptoms in the evaluation of psychosis in the Fifth Edition of the Diagnostic and Statistical Manual for Mental Disorders (DSM-5).

Keywords: Cognition; DSM-5; Diagnosis; Dimensions; Psychosis; Schizoaffective.

Similar articles

  • Structure of the Psychotic Disorders Classification in DSM-5
    S Heckers et al. Schizophr Res 150 (1), 11-4. PMID 23707641. - Review
    Schizophrenia spectrum disorders attract great interest among clinicians, researchers, and the lay public. While the diagnostic features of schizophrenia have remained un …
  • Schizoaffective Disorder in the DSM-5
    D Malaspina et al. Schizophr Res 150 (1), 21-5. PMID 23707642.
    Characterization of patients with both psychotic and mood symptoms, either concurrently or at different points during their illness, has always posed a nosological challe …
  • Psychotic Disorders in DSM-5: Summary of Changes
    WT Carpenter et al. Asian J Psychiatr 6 (3), 266-8. PMID 23642992.
    Key issues related to the diagnosis of schizophrenia and other psychotic disorders addressed in DSM-5 were more precisely defining diagnostic boundaries between different …
  • [The Schizophrenia Spectrum and Other Psychotic Disorders in the DSM-5]
    N Tan et al. Tijdschr Psychiatr 56 (3), 167-72. PMID 24643825. - Review
    The limitations of the classic system of categorical diagnosis are widely acknowledged and serious consideration has been given to the abolition of this type of diagnosis …
  • Psychosis
    DB Arciniegas. Continuum (Minneap Minn) 21 (3 Behavioral Neurology and Neuropsychiatry), 715-36. PMID 26039850. - Review
    This article provides practicing neurologists with updates on current approaches to the diagnosis, evaluation, and treatment of primary and secondary psychoses.
See all similar articles

Cited by 29 PubMed Central articles

See all "Cited by" articles

MeSH terms

LinkOut - more resources